CN Stock MarketDetailed Quotes

300972 Fujian Wanchen Biotechnology Group

Watchlist
  • 20.15
  • +0.78+4.03%
Market Closed Jul 19 15:00 CST
3.57BMarket Cap-27602P/E (TTM)

Fujian Wanchen Biotechnology Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fujian Wanchen Biotechnology Group Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

4.83B

+534.03%
EPS(YoY)

0.04

-89.26%
Analyst Rating

Strong Buy

Jul 19, 2024

Fujian Wanchen Biotechnology Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 23.962B--
--2024/FY-- / 20.486B--
--2023/FY9.294B / 9.528B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 23.962B--
--2024/FY-- / 20.486B--
--2023/FY9.294B / 9.528B--
--------
--------

Unlock Free Earnings Estimates

Fujian Wanchen Biotechnology Group Earnings Reports

  • Fujian Wanchen Biotechnology Group: 2024 First Quarter Report

    Apr 26 12:00 ET

  • Wanchen Group: 2023 Annual Report (after correction)

    Apr 23 05:21 ET

  • Wanchen Group: 2023 Annual Report Correction Notice

    Apr 23 05:21 ET

  • Wanchen Group: 2023 Annual Report Summary

    Apr 22 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 19, 2024

    Strong Buy

    • Strong Buy

      50.00%

    • Buy

      50.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg